Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study

The purpose of this study was to evaluate the activity, measured in terms of progression-free survival (PFS) and response rates, of 1,3-bis(chloroethyl)-1-nitrosourea (BCNU) plus temozolomide in adult patients with recurrent glioblastoma multiforme. The phase 2 dose and schedule for this trial was B...

Full description

Saved in:
Bibliographic Details
Main Authors: Prados, Michael D., Yung, W.K. Alfred, Fine, Howard A., Greenberg, Harry S., Junck, Larry, Chang, Susan M., Nicholas, M. Kelly, Robins, H. Ian, Mehta, Minesh P., Fink, Karen L., Jaeckle, Kurt A., Kuhn, John, Hess, Kenneth R., Schold, S. Clifford
Format: Artigo
Language:Inglês
Published: Duke University Press 2004
Subjects:
Clinical Investigations
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1871975/
https://ncbi.nlm.nih.gov/pubmed/14769138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/S1152851703000309
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items